Owens & Minor, Inc. (NYSE:OMI) SVP Jonathan A. Leon Sells 5,000 Shares

Owens & Minor, Inc. (NYSE:OMI) SVP Jonathan A. Leon sold 5,000 shares of Owens & Minor stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $18.62, for a total value of $93,100.00. Following the completion of the sale, the senior vice president now owns 98,213 shares of the company’s stock, valued at $1,828,726.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Owens & Minor Trading Up 1.3 %

NYSE:OMI opened at $19.00 on Tuesday. The company has a debt-to-equity ratio of 2.38, a current ratio of 1.23 and a quick ratio of 0.60. Owens & Minor, Inc. has a one year low of $11.79 and a one year high of $22.86. The company has a market cap of $1.45 billion, a PE ratio of -12.34, a PEG ratio of 4.56 and a beta of 0.35. The firm has a 50-day moving average of $16.13 and a 200-day moving average of $17.13.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Friday, November 3rd. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.06. The business had revenue of $2.59 billion during the quarter, compared to the consensus estimate of $2.58 billion. Owens & Minor had a positive return on equity of 8.06% and a negative net margin of 1.14%. The company’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.41 EPS. As a group, equities research analysts expect that Owens & Minor, Inc. will post 1.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

OMI has been the subject of several research analyst reports. Credit Suisse Group lifted their price objective on shares of Owens & Minor from $18.00 to $19.00 and gave the company a “neutral” rating in a research note on Tuesday, August 8th. TheStreet lowered shares of Owens & Minor from a “c-” rating to a “d+” rating in a report on Thursday, October 12th. Citigroup reduced their target price on Owens & Minor from $23.00 to $21.00 in a research note on Friday, August 4th. StockNews.com started coverage on Owens & Minor in a research report on Thursday, October 5th. They issued a “hold” rating for the company. Finally, JPMorgan Chase & Co. cut their price target on Owens & Minor from $21.00 to $19.00 and set an “underweight” rating on the stock in a report on Friday. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company’s stock. According to MarketBeat.com, Owens & Minor presently has a consensus rating of “Hold” and a consensus price target of $20.80.

Institutional Investors Weigh In On Owens & Minor

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Nomura Asset Management Co. Ltd. raised its holdings in shares of Owens & Minor by 68.3% in the first quarter. Nomura Asset Management Co. Ltd. now owns 1,700 shares of the company’s stock valued at $25,000 after purchasing an additional 690 shares during the last quarter. Lindbrook Capital LLC increased its stake in Owens & Minor by 60.6% in the 2nd quarter. Lindbrook Capital LLC now owns 1,487 shares of the company’s stock valued at $28,000 after buying an additional 561 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new position in shares of Owens & Minor during the 3rd quarter worth approximately $29,000. Versant Capital Management Inc boosted its stake in shares of Owens & Minor by 147.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,593 shares of the company’s stock worth $30,000 after buying an additional 948 shares during the last quarter. Finally, Quadrant Capital Group LLC grew its holdings in shares of Owens & Minor by 51.3% in the second quarter. Quadrant Capital Group LLC now owns 2,437 shares of the company’s stock valued at $46,000 after acquiring an additional 826 shares in the last quarter. 98.04% of the stock is owned by hedge funds and other institutional investors.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.